SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000078003-20-000065
Filing Date
2020-10-27
Accepted
2020-10-27 08:11:48
Documents
18
Period of Report
2020-10-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pfe-20201027.htm   iXBRL 8-K 59920
2 EX-99 pfe-09272020xex99.htm EX-99 3162591
8 oldpfelogowhitea011a.jpg GRAPHIC 95575
9 pfizerlogo2019a011a.jpg GRAPHIC 15668
10 upjohnlogoa041a.jpg GRAPHIC 230605
  Complete submission text file 0000078003-20-000065.txt   4005528

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pfe-20201027.xsd EX-101.SCH 3210
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pfe-20201027_cal.xml EX-101.CAL 717
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pfe-20201027_def.xml EX-101.DEF 16025
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pfe-20201027_lab.xml EX-101.LAB 31785
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pfe-20201027_pre.xml EX-101.PRE 16704
11 EXTRACTED XBRL INSTANCE DOCUMENT pfe-20201027_htm.xml XML 15267
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-03619 | Film No.: 201262095
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences